Cytotoxic Chemotherapy
134 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.
Cytotoxic Chemotherapy (117)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Decitabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Decitabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Decitabine-Cedazuridine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Decitabine-Cedazuridine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Diflomotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Diflomotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Docetaxel |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Docetaxel
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Doxifluridine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Doxifluridine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Doxorubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Doxorubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Edatrexate |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Edatrexate
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Emitefur |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Emitefur
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Eniluracil |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Eniluracil
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Epirubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Epirubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Eribulin |
Antimicrotubule Agent | Both (Solid & Hematologic) | ||
|
Molecule
Eribulin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
||||
Estramustine Phosphate |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Estramustine Phosphate
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
DecitabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Decitabine-CedazuridineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
DiflomotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
DocetaxelCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
DoxifluridineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
DoxorubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
EdatrexateCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
EmitefurCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
EniluracilCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
EpirubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
EribulinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimicrotubule Agent |
|
Estramustine PhosphateCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|